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Abstract Understanding the aetiology and progression of
atopic dermatitis and respiratory allergy may elucidate early
preventative and management strategies aimed towards reduc-
ing the global burden of asthma and allergic disease. In this
article, we review the current opinion concerning the link
between atopic dermatitis and the subsequent progression of
respiratory allergies during childhood and into early adoles-
cence. Advances in machine learning and statistical method-
ology have facilitated the discovery of more refined defini-
tions of phenotypes for identifying biomarkers. Understand-
ing the role of atopic dermatitis in the development of respi-
ratory allergy may ultimately allow us to determine more ef-
fective treatment strategies, thus reducing the patient and eco-
nomic burden associated with these conditions.
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Introduction
Understanding the aetiology and progression of atopic derma-
titis and respiratory allergy may elucidate early preventative
and management strategies aimed towards reducing the global
burden of asthma and allergic disease [1, 2]. There is increas-
ing interest in determining the causes of atopic dermatitis and
respiratory allergies, especially in the light of the increasing
prevalence and economic burden associated with these condi-
tions. Globally, up to 20 % of children suffer from atopic
dermatitis [3]. According to the 2014 Global Asthma Report,
it is estimated that 334 million people have asthma with 14 %
of the world’s children and 8.6 % of young adults exhibiting
asthma symptoms [4]. Allergic rhinitis has a maximum global
prevalence of 40 %. In the UK alone, the yearly financial
burden of these three conditions is over £2.5 billion per year
[3, 5–7]. It is hoped that research into underpinning the causal
mechanisms of atopic dermatitis and respiratory allergy can
help to ameliorate the global burden of these conditions.
To date, the majority of research in understanding the link
between atopic dermatitis and respiratory allergy has focused
on establishing causal mechanisms via the existence of the
supposed Batopic march^ of allergic symptoms. The term
Batopic march^ refers to the temporal progression of symp-
toms during childhood from atopic dermatitis to asthma to
allergic rhinitis [2, 8, 9•, 10–14]. This hypothesis is based on
the observation that clinical signs of atopic dermatitis often
occur earlier in life and often asthma and allergic rhinitis occur
later on in life. This observation has widely led to the conclu-
sion that atopic dermatitis is a causal Bentry point^ for subse-
quent asthma and allergic rhinitis [13]. Consequently, it has
been suggested that effective management of atopic dermatitis
could deter the progression of the atopic march, therefore
preventing or at least reducing the subsequent development
of asthma and allergic rhinitis. This conceptual framework has
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been the basis for studies aiming to prevent the development
of airway inflammation and asthma in children who were
deemed to be at risk by virtue of having atopic dermatitis
and a family history of atopic disease [15•]. However, there
is no evidence that targeting children with atopic dermatitis
with an intervention designed to modify the progression to-
wards asthma is effective [16].
The hypothesis of the atopic march as an explanation of the
causal link between atopic dermatitis and respiratory allergies
may be erroneously based on evidence on a population level
without taking into account the profile of symptoms at the
individual level. Using an epidemiological approach based
on the prevalence of allergic diseases on a population level,
we observe that atopic dermatitis has an increased prevalence
in early life across the population followed by an increase in
the prevalence of asthma with a subsequent increase in the
prevalence of allergic rhinitis (Fig. 1a). Such an approach
hinders a deeper understanding of the progression of symp-
toms at an individual level and determining whether such a
progression of symptoms is indeed observed within individ-
uals with an increased risk of atopic dermatitis in early life.
Studies conducted investigating genetic and other biological
markers of atopic dermatitis and other allergic diseases have
raised the question as to whether atopic dermatitis is a cause of
the subsequent development of asthma and allergic rhinitis or
whether the presence of atopic dermatitis in early life is a
consequence of distinct syndromes with different pathophys-
iological mechanisms for the subsequent development of re-
spiratory allergy [13].
This article focuses on reviewing our current understanding
of the link between atopic dermatitis and the subsequent pro-
gression of respiratory allergies during childhood and into
early adolescence. When considering respiratory allergies,
we will focus on asthma and rhinitis which are commonly
described as allergic conditions. Indeed, the purpose of under-
standing allergic disease progression is with the view of de-
veloping targeted, personalised treatment and management
strategies. Understanding the role of atopic dermatitis in the
development of respiratory allergy may ultimately allow us to
determine more effective treatment strategies, thus reducing
the patient and economic burden associated with these
conditions.
Atopic Dermatitis and Respiratory Allergy: How are they
Linked? Current Understanding in the Literature
Several studies have hypothesised that the presence of atopic
dermatitis within the first 2 years of life predicts subsequent
asthma followed by rhinitis in later childhood [8, 9•, 10–14,
15•]. In the mid-twentieth century, this triad of symptoms was
first hypothesised to be causally linked via the mechanism of
the allergic or atopic march [17]. Later, at the beginning of the
twenty-first century, with the increase in epidemiological stud-
ies, publications dealing with asthma and allergic diseases
gave evidence at a population level to suggest a causal link
between atopic dermatitis and subsequent asthma and allergic
rhinitis.
Most of the studies which associated early-life atopic der-
matitis with an increased risk of subsequent asthma and aller-
gic rhinitis used cross-sectional statistical analysis techniques
which do not take into account the temporal development of
symptoms at a within-individual level [8, 11, 17–24]. The
atopic march hypothesis has been criticised as an oversimpli-
fication of what happens to the disease profile on an individual
A B
Fig. 1 Illustration showing that the atopic march may be the result of an
ecological fallacy whereby the profiles of atopic dermatitis (eczema)
wheeze and rhinitis follow a profile similar to the atopic march when
looking at prevalence at a population level (a) [32•]. However, when
we disaggregate profiles of symptoms at an individual level, we identify
eight distinct profiles of co-occurrence of eczema, wheeze and rhinitis (b)
[32•]. Data is derived from joint profiles of the Avon Longitudinal Study
of Parents and Children (ALSPAC) and Manchester Asthma and Allergy
Study (MAAS)
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level [25–28], and some studies have suggested that among
patients there is heterogeneity in the chronology of the devel-
opment of symptoms [28–30, 31•, 32•, 33]. Children with
early atopic dermatitis who later develop asthma and rhinitis
may belong to a distinct phenotype, rather than represent the
typical progression of atopic diseases within the general pop-
ulation [28, 30]. Despite apparent clear temporal association
linking atopic dermatitis with progression to asthma and aller-
gic rhinitis, there is no definitive proof that atopic march is
causal or that atopic dermatitis is causal for the subsequent
development of asthma and rhinitis [31•]. As there is little
novelty in the conclusions and statistical-epidemiological
methods used to assess whether atopic dermatitis is causally
related to the subsequent development of asthma followed by
allergic rhinitis via an atopic march of these symptoms, we
merely acknowledge this as a widely hypothesised causal
mechanism which has already been extensively reviewed in
the literature [32•, 33]. In the following part of this section, we
will highlight studies which have utilised more novel ap-
proaches to understanding the underlying heterogeneity in
the manifestation of atopic dermatitis and respiratory allergy
in childhood.
A recent study from the ORCA Cohort applied cluster
analysis to evaluate whether distinct phenotypes of early-
onset atopic dermatitis had different risk associated with the
subsequent development of asthma [34]. Cluster analysis on
214 children with early-onset atopic dermatitis revealed two
phenotypes of disease progression: a phenotype of multiple
sensitisations (39 %) and another phenotype predominantly
linked with family history of asthma (17 %), whereas 44 %
of these children did not go on to develop subsequent asthma/
allergy. Therefore, among children with early-onset atopic
dermatitis, where we would expect the atopic march to be
more pronounced, nearly half of these children do not develop
the subsequent symptoms associated with the atopic march.
The study concludes that the hypothesis that a Bsingle entry^
mechanism whereby atopic dermatitis leads to the subsequent
development of asthma and allergic rhinitis is observed in a
subgroup of children with multiple sensitisation. Therefore
there may exist various pathophysiological mechanisms
which lead to the atopic march progression from atopic der-
matitis to asthma and then allergic rhinitis and different path-
ways of progression of allergic disease may be associated to
different genetic, environmental and genetic-environmental
influences.
A study of ∼310,000 children born in Taiwan [35] evalu-
ated the different courses of atopic dermatitis and their rela-
tionships to subsequent asthma and allergic rhinitis. This
study superimposed phenotypes defined by Illi et al. [36] for
subtypes of atopic dermatitis and phenotypes defined byMar-
tinez et al. [37•] for different subtypes of wheeze. This ap-
proach led them to conclude that although the profile was
similar to previous studies, the paradigm of the atopic march
may have been an oversimplification of the profile that exists
on an individual level with different atopic dermatitis pheno-
types having significantly different risks of subsequent devel-
opment of asthma and allergic rhinitis.
In a recent study [32•], we jointly modelled longitudinal
data from two independent population-based birth cohorts:
The Avon Longitudinal Study of Parents and Children
(ALSPAC) Cohort and the Manchester Asthma and Allergy
Study (MAAS) Cohort. The aim of this study was to investi-
gate whether the atopic march profile which is observed on a
population level can be observed on a within-individual level.
This study consisted of atopic dermatitis, wheeze and rhinitis
data from both cohorts which was collected from each child at
ages 1, 3, 5, 8 and 11 years of age. This was the first study to
investigate the presence of distinct individual-level profiles
using a machine learning approach to infer the presence of
different hypothetical latent classes which represent different
profiles of atopic dermatitis, wheeze and rhinitis over time. In
this study, we identified eight different classes describing dis-
tinct subgroups of temporal trajectories of atopic dermatitis,
wheeze and rhinitis during childhood. Based on the character-
istics of these classes, they were labelled as: no disease
(51.3 %), atopic march (3.1 %), persistent atopic dermatitis
and wheeze (2.7 %), persistent atopic dermatitis with later-
onset rhinitis (4.7 %), persistent wheeze with later-onset rhi-
nitis (5.7 %), transient wheeze (7.7 %), atopic dermatitis only
(15.3 %) and rhinitis only (9.6 %). Less than 7 % of children
with symptoms had profiles similar to those of the atopic
march, in which early atopic dermatitis and wheeze were
followed by rhinitis. The remaining disease classes were gen-
erally characterised by the presence of only one or two of the
three symptoms, indicating that more than 90 % of children
with symptoms commonly associated with atopy in childhood
do not follow the widely perceived trajectory of the atopic
march. Furthermore, highly concordant patterns of sensitisa-
tion over time were associated with very different profiles of
symptoms. Conversely, for the three classes characterised by
persistence of wheeze (atopic march, persistent atopic derma-
titis and wheeze, persistent wheeze with later-onset rhinitis)
patterns of sensitisation were different, as were patterns of co-
morbid atopic dermatitis and rhinitis. This may give evidence
to suggest that atopic dermatitis, asthma and allergic rhinitis
are all common and so co-exist, but mostly as independent
entities. Although there is a group of children with trajectories
similar to the atopic march paradigm andwith a high degree of
allergic sensitisation, this only comprises approximately one
child in every 20 with symptoms.
In this study [32•], we also explicitly modelled the assump-
tions underlying the atopic march (that the profile of this
march of symptomsmay follow a chronological manifestation
of atopic dermatitis, wheeze and then rhinitis) and found that,
using the mathematical criteria of model evidence which is a
measure of model likelihood, this model does not capture
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patterns in the data as well as a model in which we assumed
that atopic dermatitis, wheeze and rhinitis are independent.
This suggested that a profile of symptoms where we assume
that atopic dermatitis, asthma and allergic rhinitis are distinct,
independent diseases with different patterns of co-occurrence
better encapsulated the profile of symptoms on a population
level, than a model where we assume that the probability of
developing subsequent respiratory allergy is conditioned on
prior symptoms of atopic dermatitis. These distinct profiles
with different associated factors may suggest distinct mecha-
nisms: one which leads to atopic sensitization and those lead-
ing to symptoms. This is consistent with recent discovery of
different phenotypes of atopy characterised by different pat-
terns of IgE responses to allergens (both over time, and to
different individual allergens), which differ in their associa-
tions with clinical symptoms [38•, 39, 40].
Previous studies which suggest evidence of an atopic
march of symptoms from atopic dermatitis to respiratory al-
lergy may be a have a flawed approach as they reflect patterns
at the population level, rather than the natural covariance of
symptoms within individuals’ life courses. A recent review
has challenged the lack of robust evidence for inferring that
atopic dermatitis is causally linked to asthma and rhinitis
[31•]. The link between atopic dermatitis and respiratory al-
lergy may not be causal, but may rather be explained by an
underlying latent (non-observed) disease status within the
population, whose structure we were able to infer by investi-
gating individual longitudinal disease profiles.
Although generally acknowledged that children with atopic
dermatitis are at an increased risk of respiratory allergic dis-
eases and atopic sensitisation, there is a need to move away
from the traditional atopic march paradigm. The observed
atopic march may be the result of an ecological fallacy where-
by we observe a global prevalence profile of atopic dermatitis
followed by asthma followed by allergic rhinitis at a popula-
tion level, however, this profile of symptoms may not be ob-
served when we look at trajectories of disease within individ-
uals. Figure 1 illustrates where such a phenomenon occurs
with the atopic march where at a population level, we observe
profiles similar to those of the atopic march (Fig. 1a). How-
ever, using latent variable modelling, we identify distinct phe-
notypes with distinct profiles of co-occurrence between ecze-
ma, wheeze and rhinitis and only a subgroup of these profiles
follow those similar to the atopic march. Most children with
early atopic dermatitis will not develop asthma. Rather, there
is a need for clinicians to acknowledge the heterogeneity of
patterns of Ballergic^ diseases and to communicate to parents
the uncertainty inherent in predicting the development of new
symptoms or resolution of existing ones. This is a more real-
istic approach involving the disaggregation of a complex phe-
notype with the aim to understand different mechanisms asso-
ciatedwith the subsequent development of asthma and allergic
diseases. This would lead us towards a better understanding of
different causes of heterogeneous pathways for asthma and
allergic disease development.
Statistical Machine Learning to Refine
our Understanding of Distinct Disease Phenotypes
Recent developments in machine learning provide new ways
to capture heterogeneity in longitudinal patterns of distinct
symptom categories within individual patients, where conven-
tional modelling techniques might over-aggregate the under-
lying disease complexity [41]. Machine learning allows us to
utilise a data-driven approach to identify structure within the
data. Latent variable modelling is one such method of pattern
recognition which can be applied to classify homogenous
group patients. These methods are used commonly by com-
puter scientists for problem-solving in many other fields and
are increasingly used to disaggregate complex disease pheno-
types in respiratory medicine and allergy [32•, 38•, 39–43].
Methodological development within this area can greatly en-
hance our ability to understand asthma and allergic disease
heterogeneity in order to discover latent phenotypes which
are replicable across different populations. It is hoped that
such phenotypes will be clinically meaningful and have prac-
tical implications for our understanding of these conditions
and how they are managed in the future.
The use of latent variablemodelling strategies has been crucial
in helping to disaggregate complex phenotypes where oversim-
plification of statistical associations may be an impediment to
understanding underlying causal factors. An example of such a
disaggregation of a complex phenotype is in the case of asthma,
where latent variable modelling was used to understand the dif-
ferent subtypes of wheezing illness which have been placed un-
der the umbrella term of asthma [44–46]. This led to understand-
ing that asthma, rather than being a single disease, is an umbrella
term used to define multiple conditions which display similar
symptoms but have different triggers and manifestations over
time. In order to identify causal associations and understand the
co-existence of atopic dermatitis and respiratory allergy, a more
refined phenotypic definition is a fundamental ingredient. Such a
phenotypic definition will enhance our current understanding of
the within-person variability in disease atopic dermatitis, asthma
and rhinitis profiles and between-patient heterogeneity in disease
development. These modelling strategies provide a flexible
modelling framework whereby we can incorporate appropriate
levels ofmodel complexity and at the same time use a data-driven
rather than hypothesis testing approach for developing model
inferences to better understand disease development over time.
Together with enhanced statistical machine learning
modelling frameworks which allow us to incorporate appro-
priate levels of complexity and uncertainty in discovering het-
erogeneous phenotypes, medical data science is rapidly mov-
ing towards a systems approach to understand the underlying
causality of disease heterogeneity. A systems approach may
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lead to a better understanding of disease heterogeneity through
multi-scale subtype discovery based on clinical data to incor-
porate genetic, biological and molecular data using an integra-
tive systems biology approach to endotype discovery. Such an
approach providesmanymethodological challenges due to the
data complexity and computational expense involved in such
models. However, it is worth pursuing this area of research,
not only within allergy and respiratory medicine, but such
approaches will be applicable to a more generalised medical
framework for understanding disease complexity in other
areas as well.
Biomarkers as a Tool for Identifying Distinct Phenotypes
There is a need for diagnostic tools such as biomarkers which
can be used to predict different causal mechanisms and man-
ifestation of symptoms. Given our understanding that the co-
occurrence of atopic dermatitis, asthma and allergic rhinitis
may have heterogeneous manifestations, some of which may
resemble the profile of the hypothesised atopic march, future
work may be carried out to investigate whether there are un-
derlying biological and genetic markers indicating distinct
mechanisms for these heterogeneous profiles of symptoms.
A recent review [44] highlighted the fact that the increasing
prevalence of atopic dermatitis in the global population was sug-
gestive that atopic dermatitis is not only due to heritability, but
that there are other environmental effects as well as genetic fac-
tors that are modified by the environment (gene–environment
interactions). As with many other studies [28, 30, 31•, 32•, 33],
this review also highlighted the importance of understanding
different subgroups of atopic dermatitis which have different
subsequent associations with asthma and allergic rhinitis.
Unravelling the complex genetic architecture underlying atop-
ic dermatitis and respiratory allergy and the different profiles of
co-manifestation of these symptoms is an important premise for
future therapies and potentially disease-modifying strategies [47].
However, because of the high degree of stratification suggested
by the large number of heterogeneous profiles, identification of
distinct biomarkers and implementation of more targeted treat-
ment and management interventions may prove challenging due
to a reduced sample size, but may also prove more effective due
to a more accurate definition of distinct disease phenotypes.
One potential biomarker for the development of the atopic
march profile of symptoms has been thymic stromal
lymphopoietin (TSLP) [48]. Early presence of circulating
TSLP was significantly associated with reduced incidence of
recurrent wheeze in those children not sensitised to
aeroallergen. These findings suggest a possible underlying
distinction between pathogenesis of developing atopic vs.
non-atopic recurrent wheeze. This may also be indicative of
an uncoupling of mechanisms atopic dermatitis associated
with different pathways, some of which are not causal. Previ-
ous studies: These findings raise the hypothesis that a cytokine
(presumably TSLP) produced by the skin acts as a messenger
to prime lung responses to allergen. If so, TSLP would be an
excellent therapeutic target to reduce the incidence of asthma
in children with a history of AD [48–51].
Another potential biomarker has been investigating the role
of fillaggrin in the subsequent development of atopic derma-
titis and subsequent atopic asthma and allergic rhinitis and
whether this plays a role in children who exhibit a symptom
profile similar to that of the atopic march [33, 52].
Conclusions
The emphasis on the Batopic march^ without robust evidence
to support this notion may hamper research into the underpin-
ning the pathophysiology of atopy-related diseases [32•]. The
current evidence suggests that the developmental profiles of
atopic dermatitis, asthma and rhinitis are heterogeneous and
that a small proportion of children with co-morbid symptoms
follow a trajectory profile similar to that of the atopic march.
Two important lessons can be drawn from the review of the
literature and should be taken as a general backdrop for re-
search when assessing the link between atopic dermatitis and
respiratory allergy. Firstly, although we acknowledge that
there is a strong association between atopic dermatitis and
respiratory allergy, association is not a sufficient condition to
imply that these conditions are causally linked. Secondly, giv-
en the distinct observed profiles of atopic dermatitis, asthma
and allergic rhinitis, we can infer that the manifestations of
allergic symptom development over time are heterogeneous.
This is a fundamental step towards understanding the causes
of respiratory allergy. The distinct subgroups of symptom pro-
files may represent distinct causal mechanisms of allergic dis-
ease. The next phase of research on understanding the link
between atopic dermatitis and respiratory allergies should be
focused on a more unified approach to replicate endotypes
discovered and to identify biomarkers for these distinct symp-
tom profiles.
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